Thomas D. Szucs
Chairman presso Helsana Versicherungen AG
Profilo
Thomas D.
Szucs is currently the Chairman at Helsana Versicherungen AG, Biovertis AG, Helsana AG, and the University of Basel.
He is also the Director of the Pharmaceutical Medicine Institute at the University of Basel and the Director of Kantonsspital Uri.
Previously, he served as the Director of the European Center of Pharmaceutical Medicine, AB2 Bio SA, and Gemelli Molise SpA.
He was also a Professor at the University of Milan and held positions as the President of the Swiss Association for Health Economics and Vice President of the Swiss Group for Clinical Research.
In his former roles, he was the Chairman of BB Biotech AG, Intercell AG, and.
BioXell SpA.
He also served as the Director of Okairos AG and a Consultant at Arthur D.
Little, Inc. Additionally, he held the position of Chief Medical Officer at Hirslanden Holding AG and was an Associate Professor at the University of Zurich.
He obtained a graduate degree from Harvard University, an MBA from the University of St. Gallen, and a doctorate from the University of Basel.
Posizioni attive di Thomas D. Szucs
Società | Posizione | Inizio |
---|---|---|
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Chairman | - |
University of Basel | Corporate Officer/Principal | 17/11/2010 |
European Center of Pharmaceutical Medicine | Director/Board Member | 25/02/2013 |
Helsana Versicherungen AG
Helsana Versicherungen AG Multi-Line InsuranceFinance Helsana Versicherungen AG provides health and accident insurance services. It offers solutions in the areas of basic, supplementary, and accident insurance which protect people against financial consequences of illnesses, unfortunate incidents, disability, maternity, and long-term care in old age. The company was founded on June 20, 1996 and is headquartered in Duebendorf, Switzerland. | Chairman | 17/11/2010 |
University of Milan | Corporate Officer/Principal | 17/11/2010 |
Swiss Association for Health Economics | President | - |
Kantonsspital Uri | Director/Board Member | - |
Swiss Group for Clinical Research | Corporate Officer/Principal | - |
Helsana AG
Helsana AG Life/Health InsuranceFinance Helsana AG provides insurance services. It offers life, accidental and medical insurance for employer groups, association groups, families and individuals. The company is headquartered in Dubendor, Switzerland. | Chairman | - |
░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Precedenti posizioni note di Thomas D. Szucs
Società | Posizione | Fine |
---|---|---|
░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░ | ░░░░░░░░ | - |
░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Formazione di Thomas D. Szucs
Harvard University | Graduate Degree |
University of St. Gallen | Masters Business Admin |
University of Basel | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BB BIOTECH AG | Finance |
Aziende private | 16 |
---|---|
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Health Technology |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | Health Technology |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Hirslanden Holding AG | Health Services |
Helsana Versicherungen AG
Helsana Versicherungen AG Multi-Line InsuranceFinance Helsana Versicherungen AG provides health and accident insurance services. It offers solutions in the areas of basic, supplementary, and accident insurance which protect people against financial consequences of illnesses, unfortunate incidents, disability, maternity, and long-term care in old age. The company was founded on June 20, 1996 and is headquartered in Duebendorf, Switzerland. | Finance |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Health Technology |
Okairos AG
Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Kantonsspital Uri | |
European Center of Pharmaceutical Medicine | |
Helsana AG
Helsana AG Life/Health InsuranceFinance Helsana AG provides insurance services. It offers life, accidental and medical insurance for employer groups, association groups, families and individuals. The company is headquartered in Dubendor, Switzerland. | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Swiss Association for Health Economics | |
Swiss Group for Clinical Research | |
Gemelli Molise SpA
Gemelli Molise SpA Hospital/Nursing ManagementHealth Services Founded in 2002, Gemelli Molise SpA is a hospital operator that is part of Università Cattolica del Sacro Cuore Campus di Milano. The private company is based in Campobasso, Italy. | Health Services |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Thomas D. Szucs